Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-25-000056
Filing Date
2025-06-27
Accepted
2025-06-27 16:43:47
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20250331.htm   iXBRL 10-Q 757621
2 EX-10.1 exhibit101sharepurchaseagmt.htm EX-10.1 216956
3 EX-10.2 exhibit102liccollabagmt.htm EX-10.2 224710
4 EX-10.5 exhibit105altaagmt.htm EX-10.5 10595
5 EX-31.1 exicureexhibit311-33125.htm EX-31.1 7745
6 EX-31.2 exicureexhibit312-33125.htm EX-31.2 7760
7 EX-32.1 exicureexhibit321-33125.htm EX-32.1 8225
  Complete submission text file 0001698530-25-000056.txt   5185748

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250331.xsd EX-101.SCH 47811
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20250331_cal.xml EX-101.CAL 66135
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20250331_def.xml EX-101.DEF 176484
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250331_lab.xml EX-101.LAB 451050
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250331_pre.xml EX-101.PRE 326245
81 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250331_htm.xml XML 510705
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 251087102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)